Today, 8:40 AMPrenetics CEO and CFO buy $1.0 million of shares in open-market purchases, lifting personal investment to about $3.75 million since November 2025

Peers: VCYT CDNA GH IDXX NTRA CRL MEDP DGX LH OMCL

Index	-
Market Cap	441.53M
Enterprise Value	332.73M
Income	-67.61M
Sales	142.56M
Book/sh	5.56
Cash/sh	6.38
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	98
IPO	Jul 16, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	3.10
P/B	4.63
P/C	4.04
P/FCF	-
EV/EBITDA	-
EV/Sales	2.33
Quick Ratio	3.66
Current Ratio	4.04
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-1.06
EPS next Q	-0.59
EPS this Y	20.45%
EPS next Y	64.84%
EPS next 5Y	-
EPS past 3/5Y	58.51% 34.71%
Sales past 3/5Y	91.46% -23.93%
EPS Y/Y TTM	-5.43%
Sales Y/Y TTM	182.05%
EPS Q/Q	49.36%
Sales Q/Q	210.67%
Earnings	Aug 18 BMO
EPS/Sales Surpr.	37.70% -6.74%

Insider Own	22.04%
Insider Trans	1.28%
Inst Own	7.06%
Inst Trans	-16.95%
ROA	-39.86%
ROE	-57.62%
ROIC	-72.58%
Gross Margin	63.22%
Oper. Margin	-35.48%
Profit Margin	-47.43%
SMA20	31.40%
SMA50	33.45%
SMA200	43.49%
Trades

Shs Outstand	15.15M
Shs Float	13.37M
Short Float	4.41%
Short Ratio	2.61
Short Interest	0.59M
52W High	23.63 8.99%
52W Low	7.25 255.24%
Volatility	11.18% 8.08%
ATR (14)	1.84
RSI (14)	74.04
Beta	0.29
Rel Volume	3.34
Avg Volume	225.85K
Volume	691,035

Perf Week	37.29%
Perf Month	41.05%
Perf Quarter	49.22%
Perf Half Y	52.04%
Perf YTD	63.52%
Perf Year	255.24%
Perf 3Y	273.26%
Perf 5Y	-76.98%
Perf 10Y	-
Recom	1.00
Target Price	35.25
Prev Close	23.25
Price	25.75
Change %	10.77%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-26	Initiated	The Benchmark Company	Buy	$30
Mar-16-26	Initiated	Lake Street	Buy	$29
Feb-11-26	Initiated	Roth Capital	Buy	$36
Jan-18-23	Initiated	Cantor Fitzgerald	Overweight	$7

Today 08:38AM	Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results (GlobeNewswire) +10.77%
Aug-20-26 09:02PM	Prenetics Global Ltd (PRE) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ... (GuruFocus.com) +12.41%
09:00AM	Prenetics' IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership (GlobeNewswire)
Aug-19-26 08:30AM	Prenetics Global Limited Q2 2026 Earnings Call Summary (Moby)
Aug-18-26 07:30AM	Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond (GlobeNewswire)
09:16AM	Loading…
Aug-17-26 09:16AM	Earnings To Watch: Prenetics Global Ltd (PRE) Q2 2026 -- GF Value Sees 256% Upside (GuruFocus.com)
08:30AM	Prenetics, Parent of IM8, Appoints II Ranked, Caroline Levy, Veteran Wall Street Consumer Analyst as Independent Director (GlobeNewswire)
Aug-07-26 08:30AM	Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation (GlobeNewswire)
Jul-14-26 01:35PM	Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF) (GlobeNewswire) +13.70%
Jun-10-26 08:30AM	Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue (GlobeNewswire) -8.03%
Jun-04-26 08:30AM	Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion (GlobeNewswire)
May-20-26 04:51PM	Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder (IPO-Edge.com) +5.85%
08:00AM	Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership (GlobeNewswire)
May-14-26 07:03PM	Prenetics Global Ltd (PRE) Q1 2026 Earnings Call Highlights: Record Revenue Surge Amid ... (GuruFocus.com) -11.26%
08:05AM	Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8 (GlobeNewswire)
08:00AM	Loading…
08:00AM	Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M-$210M (GlobeNewswire)
May-08-26 08:30AM	Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call (GlobeNewswire)
May-07-26 08:30AM	Prenetics' IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership (GlobeNewswire)
Apr-17-26 06:07AM	Pensana banks $15m tranche from Cascade as it advances Longonjo rare earth project (Proactive)
Apr-14-26 08:00AM	Prenetics' IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One (GlobeNewswire)
Apr-02-26 09:00AM	Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership (GlobeNewswire)
Mar-24-26 11:00AM	Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation (GlobeNewswire)
Mar-18-26 08:30AM	Prenetics to Participate in the 38th Annual ROTH Conference (GlobeNewswire)
08:00AM	Sidoti Events, LLC's March Small-Cap Virtual Conference (ACCESSWIRE)
Mar-06-26 08:00AM	Prenetics Authorizes $40 Million Share Repurchase Program (GlobeNewswire) +18.12%
Mar-03-26 10:19AM	Prenetics Global (PRE) Reports 480% Revenue Surge Driven by IM8 Brand Launch (Insider Monkey)
08:00AM	Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million- Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million (GlobeNewswire)
Feb-23-26 09:00AM	Prenetics Launches IM8 Daily Ultimate Essentials PRO - A Clinical Formula with Two New Flavours (GlobeNewswire) -8.45%
Feb-19-26 08:30AM	Prenetics Global Limited Q4 2025 Earnings Call Summary (Moby)
Feb-18-26 11:55AM	Prenetics Global Q4 Earnings Call Highlights (MarketBeat) -7.73%
09:25AM	Loading…
09:25AM	Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity (GlobeNewswire)
09:11AM	Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY (GlobeNewswire)
Feb-17-26 04:30PM	Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors (GlobeNewswire)
08:00AM	Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity (GlobeNewswire)
07:22AM	Earnings To Watch: Prenetics Global Ltd (PRE) Reports Q4 2025 Result (GuruFocus.com)
Feb-13-26 08:00AM	Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder (GlobeNewswire)
Feb-11-26 09:37AM	Spotify downgraded, Dick's Sporting upgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call (GlobeNewswire)
Jan-20-26 07:15AM	Sidoti Events, LLC's January Micro-Cap Virtual Conference (ACCESSWIRE)
Jan-07-26 08:26AM	Prenetics completes sale of its 3PL distribution business (TipRanks)
Jan-06-26 08:00AM	Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million (GlobeNewswire)
Jan-05-26 09:12AM	David Beckham-Backed Health Sciences Company Kills Bitcoin Treasury Plan (Benzinga)
08:00AM	Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation (GlobeNewswire)
Jan-02-26 12:03AM	Why Is The Crypto Market Up Today? (BeInCrypto)
Jan-01-26 03:30PM	David Beckhams Health Sciences Firm Backs Down From Bitcoin Purchases in 2026 (BeInCrypto)
Dec-31-25 12:00PM	All You Need to Know About Prenetics Global (PRE) Rating Upgrade to Buy (Zacks)
Dec-30-25 07:27PM	Footballer David Beckham-Backed Healthcare Firm Will no Longer Buy Bitcoin (Cryptonews)
06:33PM	David Beckham-backed stock slips after latest announcement (TheStreet)
03:06PM	Buying bitcoin is no longer a thing for this David Beckham-backed health company (MarketWatch)
08:00AM	Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8 (GlobeNewswire)
Dec-23-25 09:08AM	Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure (GlobeNewswire) -6.91%
Dec-15-25 12:00PM	What Makes Prenetics Global Limited (PRE) a Strong Momentum Stock: Buy Now? (Zacks)
Dec-09-25 12:48PM	Sidoti Events, LLC's Year-End Virtual Investor Conference (ACCESSWIRE)
Nov-25-25 08:49AM	Prenetics Announces Upcoming Conference Participation (GlobeNewswire) +8.58%
Nov-24-25 07:30AM	Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million (GlobeNewswire) +11.20%
Nov-14-25 08:35AM	Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth (GlobeNewswire) -9.43%
Nov-10-25 07:24AM	Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History (GlobeNewswire)
Nov-07-25 07:23AM	Prenetics Global Ltd (PRE) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-25 04:05PM	Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call (GlobeNewswire) -5.64%
08:00AM	Prenetics' IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch (GlobeNewswire)
Oct-31-25 08:31AM	Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR (GlobeNewswire)
Oct-29-25 04:05PM	Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth (GlobeNewswire) +13.00%
Oct-28-25 02:20PM	Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy (GlobeNewswire) -6.50%
07:13AM	Nasdaq-Listed Healthcare Company Prenetics Secures $48M to Boost Bitcoin Treasury Strategy (Cryptonews)
Oct-27-25 10:12AM	Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy (GlobeNewswire) -21.96%
09:52AM	Prenetics Announces $48.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy (GlobeNewswire)
Oct-24-25 08:30PM	Prenetics Global Limited Announces Proposed Public Offering (GlobeNewswire)
Oct-13-25 12:00PM	Prenetics Global Limited (PRE) Is Up 13.52% in One Week: What You Should Know (Zacks)
Oct-08-25 08:04AM	Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging (GlobeNewswire)
Oct-07-25 08:30AM	Prenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8's Path to $100 Million ARR (GlobeNewswire)
Sep-30-25 08:00AM	Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore (GlobeNewswire)
Sep-25-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Prenetics Global Limited (PRE) is a Great Choice (Zacks) -10.15%
Sep-15-25 07:57AM	Prenetics CEO tells Investing.com IM8 growth and BTC strategy to drive returns (Investing.com)
Sep-12-25 08:30AM	Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End (GlobeNewswire) +13.71%
Sep-08-25 11:02AM	Prenetics' IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship (GlobeNewswire) +16.04%
Jun-26-25 04:30AM	World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder (GlobeNewswire) +15.53%
Jun-18-25 09:10AM	Healthcare Firm Prenetics Uses Kraken to Kickoff Bitcoin Treasury (CoinDesk) +23.30%
08:51AM	Prenetics Acquires $20 Million In Bitcoin To Boost Healthcare Bitcoin Treasury Strategy (Benzinga)
08:45AM	Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board (GlobeNewswire)
07:50AM	Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction (GlobeNewswire)
Jun-13-25 12:15PM	Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz (TipRanks) -12.59%
Jun-12-25 08:30AM	Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon (GlobeNewswire) +5.53%
Apr-09-25 09:00AM	IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event (GlobeNewswire) -9.86%
Mar-18-25 08:30AM	Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market (GlobeNewswire)
Mar-11-25 08:30AM	Prenetics to Participate in the 37th Annual ROTH Conference (GlobeNewswire)
Mar-05-25 08:30AM	Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance (GlobeNewswire)
Feb-11-25 08:30AM	Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve (GlobeNewswire)
Jan-21-25 08:30AM	Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham (GlobeNewswire) +6.09%
Jan-15-25 08:30AM	Prenetics' IM8 Achieves Prestigious NSF Certified for Sport for Daily Ultimate Essentials (GlobeNewswire)
Dec-19-24 08:30AM	Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements (GlobeNewswire)
Dec-06-24 08:30AM	iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 (ACCESS Newswire)
Dec-05-24 08:30AM	Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services (GlobeNewswire) +13.67%
Dec-04-24 04:05PM	Prenetics Announces Participation in December Investor Conferences (GlobeNewswire)
Nov-27-24 08:30AM	Prenetics Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-18-24 06:57AM	MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health (GlobeNewswire)
06:00AM	Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health (GlobeNewswire)
Nov-12-24 08:30AM	Sidoti Events, LLC's Virtual November Micro-Cap Conference (ACCESSWIRE)
Oct-30-24 04:15PM	Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference (GlobeNewswire)
Oct-15-24 08:30AM	Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection (GlobeNewswire) +19.13%
Oct-07-24 08:30AM	Prenetics Announces Second Quarter 2024 Financial Results (GlobeNewswire) -6.88%

Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm offers scientifically formulated supplements under the IM8 brand, sports nutrition products under the Europa platform, and direct-to-consumer DNA tests through the CircleDNA brand. It is also involved in establishing a Bitcoin treasury for the exploration of applications within the healthcare ecosystem. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and has dual headquartered in Charlotte, the United States and Hong Kong.

Co-FounderMr. Sheng Wu Yeung

Chief of Staff & VP of People & OperationsMs. Samantha Kwok

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rosin Brian J	CFO of IM8 (US) LLC	Aug 24 '26	Buy	21.19	18,000	381,420	18,000	Aug 26 08:23 AM
Rosin Brian J	CFO of IM8 (US) LLC	Aug 25 '26	Buy	22.80	5,100	116,280	23,100	Aug 26 08:23 AM
Lo Hoi Chun	Chief Financial Officer	Aug 21 '26	Option Exercise	0.00	78,551	3	566,013	Aug 24 09:43 PM
Yeung Danny Sheng Wu	Chief Executive Officer	Aug 20 '26	Option Exercise	0.00	53,953	5	137,647	Aug 24 09:41 PM
Yeung Danny Sheng Wu	Chief Executive Officer	Aug 24 '26	Buy	21.23	17,181	364,673	112,416	Aug 24 09:41 PM
Yeung Danny Sheng Wu	Chief Executive Officer	Aug 20 '26	Buy	18.31	7,500	137,325	95,235	Aug 24 09:41 PM
Leogrande Hudson Blake	Director	Aug 04 '26	Option Exercise	0.00	2,001	0	4,001	Aug 05 10:45 AM
Leogrande Hudson Blake	Director	Jul 04 '26	Option Exercise	0.00	2,000	0	2,000	Jul 07 07:35 AM
Cheng Yin Pan	Director	Jun 15 '26	Option Exercise	0.00	15,873	0	59,051	Jun 16 09:10 AM
VANDERVEEN DAVID	Director	Jun 15 '26	Option Exercise	0.00	6,944	0	45,249	Jun 16 08:38 AM

Peers: CRH MLM VMC EXP JHX MAS CARR LII AOS CX

| Held by: VXF PAVE VAW IFRA ITOT SCHX JAVA PKB DFIV OAKM

Index	-
Market Cap	24.74B
Enterprise Value	31.09B
Income	1.21B
Sales	12.19B
Book/sh	23.40
Cash/sh	1.32
Dividend Est.	0.60 (1.35%)
Dividend TTM	-
Dividend Ex-Date	Aug 18, 2026
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	19000
IPO	Jun 23, 2025

P/E	20.52
Forward P/E	15.00
PEG	0.89
P/S	2.03
P/B	1.91
P/C	33.93
P/FCF	18.73
EV/EBITDA	10.82
EV/Sales	2.55
Quick Ratio	0.73
Current Ratio	1.10
Debt/Eq	0.55
LT Debt/Eq	0.39
Option/Short	Yes / Yes

EPS (ttm)	2.18
EPS next Y	2.98
EPS next Q	1.10
EPS this Y	20.03%
EPS next Y	16.00%
EPS next 5Y	16.82%
EPS past 3/5Y	2.24% -
Sales past 3/5Y	3.28% -
EPS Y/Y TTM	1.61%
Sales Y/Y TTM	5.09%
EPS Q/Q	11.32%
Sales Q/Q	8.51%
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-7.76% 3.80%

Insider Own	10.91%
Insider Trans	0.26%
Inst Own	49.98%
Inst Trans	2.20%
ROA	4.98%
ROE	9.53%
ROIC	6.72%
Gross Margin	25.02%
Oper. Margin	15.63%
Profit Margin	9.89%
SMA20	-5.36%
SMA50	-10.33%
SMA200	-16.11%
Trades

Shs Outstand	549.78M
Shs Float	493.15M
Short Float	1.52%
Short Ratio	2.19
Short Interest	7.48M
52W High	65.13 -31.39%
52W Low	43.69 2.29%
Volatility	2.27% 2.59%
ATR (14)	1.45
RSI (14)	39.02
Beta	0.05
Rel Volume	0.66
Avg Volume	3.42M
Volume	2,051,086

Perf Week	-1.26%
Perf Month	-11.06%
Perf Quarter	-15.64%
Perf Half Y	-28.63%
Perf YTD	-16.34%
Perf Year	-12.93%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	2.04
Target Price	57.34
Prev Close	44.25
Price	44.69
Change %	0.99%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-25-26	Initiated	DA Davidson	Neutral	$50
Aug-10-26	Downgrade	RBC Capital Mkts	Sector Perform → Underperform	$48
Jul-07-26	Downgrade	Truist	Buy → Hold	$48
May-01-26	Upgrade	Vertical Research	Hold → Buy	$70
Dec-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$60
Nov-14-25	Resumed	Stephens	Overweight
Sep-09-25	Initiated	Oppenheimer	Outperform	$62
Jul-15-25	Initiated	JP Morgan	Overweight	$57
Jul-10-25	Initiated	Bernstein	Outperform	$62
Jul-01-25	Initiated	Goldman	Neutral	$57
Jun-30-25	Initiated	Jefferies	Hold	$52.50
Jun-30-25	Initiated	Erste Group	Buy
Jun-30-25	Initiated	Berenberg	Buy	$64
Jun-26-25	Initiated	BofA Securities	Neutral	$56
Jun-24-25	Initiated	UBS	Neutral	$53
Jun-24-25	Initiated	Truist	Buy	$60
Jun-24-25	Initiated	RBC Capital Mkts	Outperform	$61
Jun-24-25	Initiated	Morgan Stanley	Overweight	$62

Show Previous Ratings

Aug-24-26 04:15PM	Amrize Appoints Sam Poletti as Chief Financial Officer (Business Wire)
Aug-10-26 04:15PM	Amrize Files Form 10-Q for Second Quarter 2026 (Business Wire)
Aug-07-26 11:06PM	Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com) -8.94%
05:01PM	Amrize Ltd (AMRZ) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Amid Cost Headwinds (GuruFocus.com)
03:22AM	Amrize stock tumbles on Q2 profit miss, EBITDA guide cut (Investing.com)
04:50PM	Loading…
Aug-06-26 04:50PM	Amrize Reports Second Quarter 2026 Results (Business Wire)
Jul-20-26 09:00AM	Amrize to Acquire Rapid Redi-Mix in Dallas-Fort Worth (Business Wire)
Jul-16-26 09:00AM	Amrize Announces Date for Second Quarter 2026 Financial Results (Business Wire)
Jul-07-26 01:21PM	Amrize shares tumble as Truist downgrades on roofing pressures and cement pricing (Investing.com) -5.68%
Jun-19-26 10:30AM	Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada (Business Wire)
May-05-26 01:00AM	Amrize Launches $1 Billion Share Buyback Program (Business Wire)
May-01-26 03:01AM	Amrize Ltd (AMRZ) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Apr-29-26 04:15PM	Amrize Grows Revenue 4.7% in First Quarter and Reaffirms 2026 Guidance (Business Wire) -5.27%
Apr-21-26 04:15PM	Amrize Shareholders Approve All Proposals at 2026 Annual General Meeting (Business Wire)
Apr-15-26 10:30AM	Amrize Expands 'Made in America' Label to Nine U.S. Cement Plants (Business Wire)
08:06PM	Loading…
Mar-31-26 08:06PM	Is Amrize Ltd (AMRZ) Stock Outpacing Its Construction Peers This Year? (Quartz)
04:15PM	Amrize Appoints Baris Oran as Chief Financial Officer (Business Wire)
Mar-12-26 04:15PM	Amrize Publishes Annual Report for Fiscal Year 2025 (Business Wire)
Mar-03-26 11:00AM	Amrize Launches EVERtect High-Performance Concrete Range at CONEXPO-CON/AGG 2026 (Business Wire)
Feb-22-26 02:31AM	Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating (Insider Monkey)
Feb-18-26 04:20PM	Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas (Business Wire) +10.99%
04:03PM	Amrize Ltd (AMRZ) Q4 2025 Earnings Call Highlights: Strategic Moves and Financial Resilience (GuruFocus.com)
01:44PM	Analyst Report: Amrize AG (Morningstar Research)
10:50AM	Amrize Q4 Earnings Call Highlights (MarketBeat)
Feb-17-26 07:30PM	Amrize Ltd (AMRZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
04:15PM	Amrize Delivers Strong Free Cash Flow in 2025; Shareholder Return Plan Proposed (Business Wire)
Feb-11-26 09:05PM	Amrize Board of Directors Changes (Business Wire)
Jan-28-26 09:00AM	Amrize Announces Date for Fourth Quarter and Full-Year 2025 Financial Results (Business Wire)
Jan-20-26 08:36AM	Is the Options Market Predicting a Spike in Amrize Stock? (Zacks)
Jan-16-26 07:51AM	Amrize price target raised to $64 from $62 at Oppenheimer (TipRanks)
08:15PM	Loading…
Jan-06-26 08:15PM	Amrize to Acquire PB Materials; Aggregates Leader in High-Growth West Texas (Business Wire)
Dec-18-25 07:40AM	Who Actually Benefits From the $200 Billion Infrastructure Boom? We Compared 3 Stocks. (24/7 Wall St.)
Dec-16-25 10:00AM	Amrize Expands Production Capacity at Flagship U.S. Cement Plant (Business Wire)
Nov-13-25 11:00AM	Amrize Launches 'Made in America' Label for U.S. Builders (Business Wire)
Nov-07-25 06:02AM	Insiders Bet Big on These 2 Stocks Heres Why Analysts Think a Payoff Could Be Ahead (TipRanks)
Nov-03-25 07:28PM	Analyst Report: Amrize AG (Morningstar Research)
Oct-29-25 01:10PM	Analyst Report: Amrize AG (Morningstar Research)
Oct-28-25 07:00PM	Here's What Key Metrics Tell Us About Amrize Ltd (AMRZ) Q3 Earnings (Zacks)
04:15PM	Amrize Delivers Strong Third Quarter Revenue Growth and Free Cash Flow Generation (Business Wire)
09:20AM	Amrize Ltd (AMRZ) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-27-25 09:19AM	What To Expect From Amrize Ltd (AMRZ) Q3 2025 Earnings (GuruFocus.com)
Oct-23-25 12:04PM	Do Options Traders Know Something About Amrize Stock We Don't? (Zacks)
Oct-09-25 11:00AM	Amrize Announces Date for Third Quarter 2025 Financial Results (Business Wire)
08:51AM	America's Fading Stock Premium (The Wall Street Journal)
Sep-23-25 11:00AM	Amrize Partners with Chicago Architecture Biennial to Advance Building (Business Wire)
Sep-18-25 09:00AM	Amrize Launches Next-Generation Carrier to Further Strengthen Distribution Network for Growth (Business Wire)
Sep-16-25 04:59AM	New Strong Sell Stocks for September 16th (Zacks)
Sep-15-25 09:03AM	Amrize AG (AMRZ) Downplays TRC Capital Tender Offer (Insider Monkey)
Sep-11-25 02:15PM	Oppenheimer Initiates Coverage of Amrize (AMRZ) with Outperform Rating, Cites Growth Strategy, Strong Financials (Insider Monkey)
Sep-05-25 06:26AM	New Strong Sell Stocks for September 5th (Zacks)
Aug-29-25 06:29AM	New Strong Sell Stocks for August 29th (Zacks)
Aug-28-25 06:44PM	Amrize Recommends Shareholders Reject Mini-Tender Offer By TRC Capital Investment Corporation (Business Wire)
Aug-07-25 01:09PM	Analyst Report: Amrize AG (Morningstar Research) -6.72%
05:09AM	Amrize shares tumble 10% on big guidance miss, disappointing Q2 print (Investing.com)
Aug-06-25 04:15PM	Amrize Delivers Solid Second Quarter, Starts Journey in Position of Strength (Business Wire)
Jul-29-25 10:30AM	Here are Bronte Capital's Views on Amrize Ltd (AMRZ) (Insider Monkey)
Jul-21-25 02:00PM	Amrize Announces Date for Second Quarter 2025 Financial Results (Business Wire)
Jul-16-25 09:53AM	Amrize and Meta Partner on First-of-its-kind AI-Optimized Advanced Concrete Mix for Data Center in Minnesota (Business Wire)
Jul-03-25 11:36AM	Why Its Time to Buy This Rocks and Cement Spinoff Stock Youve Probably Never Heard Of (Barrons.com)
Jun-23-25 04:46PM	Amrize Stock Gains on First Trading Day (The Wall Street Journal)
04:35PM	Cement Firm Amrize Falls in Spinoff Debut as Holcim Jumps (Bloomberg)
08:55AM	NYSE Content Advisory: Pre-Market update + Amrize begins trading on the NYSE (PR Newswire)
12:47AM	Amrize Debuts as Independent, Publicly Traded Company (Business Wire)

Amrize Ltd. engages in selling building materials. It operates through the Building Materials and Building Envelope segments. The Building Materials segment offers cement and aggregates, as well as a variety of downstream products and solutions such as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment includes roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing and protective coatings, along with adhesives, tapes, and sealants that are critical to the application of roofing and wall systems. The company was founded on April 6, 2023 and is headquartered in Chicago, IL.

CEO & ChairmanMr. Jan Philipp Jenisch

Chief Legal Officer & Corporate SecretaryMs. Denise Rene Perry Singleton J.D.

President of Building MaterialsMr. Jaime Hill

President of Building EnvelopeMr. James J. Gosa

Chief Financial OfficerMr. Baris Oran

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singleton Denise R	Chief Legal Officer & Corp Sec	Aug 25 '26	Buy	44.12	3,500	154,402	7,500	Aug 26 10:57 AM
Forrest Nollaig	Chief Mktg & Corp Affairs Off	Aug 25 '26	Buy	44.15	1,500	66,225	21,639	Aug 25 03:53 PM
Poletti Samuel Jonas	Chief Strategy & M&A Officer	Aug 17 '26	Buy	46.92	2,510	117,769	10,155	Aug 18 12:29 PM
Clark Stephen S	Chief People Officer	Aug 11 '26	Buy	47.31	5,260	248,851	10,637	Aug 13 11:46 AM
Brouwer Roald	Chief Technology Officer	Aug 11 '26	Buy	46.36	1,500	69,540	21,490	Aug 13 11:41 AM
Gross Mario	Chief Supply Chain Officer	Aug 11 '26	Buy	46.60	3,568	166,252	38,485	Aug 13 11:29 AM
Hill Jaime	President, Building Materials	Aug 11 '26	Buy	47.12	1,500	70,680	29,698	Aug 13 11:23 AM
Oran Baris	Chief Financial Officer	Aug 11 '26	Buy	47.38	3,000	142,140	3,000	Aug 13 11:10 AM
Oran Baris	Chief Financial Officer	Aug 12 '26	Buy	47.13	3,000	141,390	6,000	Aug 13 11:10 AM
Forrest Nollaig	Chief Mktg & Corp Affairs Off	May 22 '26	Buy	50.25	2,000	100,500	20,139	May 26 01:47 PM
Brouwer Roald	Chief Technology Officer	May 21 '26	Buy	49.84	1,500	74,760	19,757	May 21 12:36 PM
Gross Mario	Chief Supply Chain Officer	May 19 '26	Buy	49.17	2,800	137,676	33,747	May 21 12:31 PM
Gross Mario	Chief Supply Chain Officer	May 20 '26	Buy	48.63	1,200	58,356	34,747	May 21 12:31 PM
Jenisch Jan Philipp	Chairman & CEO	May 19 '26	Buy	49.28	16,001	788,571	1,741,000	May 20 10:26 AM
Jenisch Jan Philipp	Chairman & CEO	May 19 '26	Buy	49.96	3,000	149,880	515,000	May 20 10:26 AM
Jenisch Jan Philipp	Chairman & CEO	May 15 '26	Buy	49.67	21,417	1,063,731	1,724,999	May 18 04:33 PM
Jenisch Jan Philipp	Chairman & CEO	May 15 '26	Buy	49.12	7,000	343,840	512,000	May 18 04:33 PM
Clark Stephen S	Chief People Officer	May 05 '26	Buy	52.75	2	114	5,260	May 07 04:35 PM
Gross Mario	Chief Supply Chain Officer	Mar 13 '26	Buy	55.29	3,200	176,936	30,947	Mar 16 01:59 PM
Brouwer Roald	Chief Technology Officer	Mar 13 '26	Buy	54.88	2,000	109,760	18,257	Mar 16 01:53 PM
Hill Jaime	President, Building Materials	Mar 12 '26	Buy	56.90	1,000	56,900	28,000	Mar 12 02:02 PM
Johnston Ian A	Chief Financial Officer	Mar 10 '26	Buy	58.94	4,250	250,474	25,110	Mar 11 02:00 PM
Hill Jaime	President, Building Materials	Mar 11 '26	Buy	58.91	1,000	58,910	27,000	Mar 11 01:56 PM
Brouwer Roald	Chief Technology Officer	Mar 11 '26	Buy	58.72	3,000	176,160	16,257	Mar 11 01:49 PM
Hill Jaime	President, Building Materials	Mar 09 '26	Buy	56.34	3,184	179,387	26,000	Mar 10 01:06 PM
Jenisch Jan Philipp	Chairman & CEO	Mar 06 '26	Buy	58.05	60,000	3,483,000	1,703,582	Mar 09 01:31 PM
Johnston Ian A	Chief Financial Officer	Feb 19 '26	Buy	63.92	1,200	76,702	18,544	Feb 23 02:25 PM
Gangestad Nicholas C	Director	Nov 19 '25	Buy	47.34	2,000	94,680	4,958	Nov 20 02:32 PM
Hill Jaime	President, Building Materials	Nov 04 '25	Buy	50.69	4,000	202,740	18,101	Nov 06 01:38 PM
Brouwer Roald	Chief Technology Officer	Oct 31 '25	Buy	51.77	4,000	207,100	9,000	Nov 04 12:09 PM
Jenisch Jan Philipp	Chairman & CEO	Oct 30 '25	Buy	52.88	55,000	2,908,400	505,000	Oct 31 11:36 AM
Jenisch Jan Philipp	Chairman & CEO	Oct 30 '25	Buy	52.64	55,000	2,895,200	1,505,000	Oct 31 11:36 AM
Brouwer Roald	Chief Technology Officer	Aug 27 '25	Buy	51.88	2,000	103,760	5,000	Aug 27 11:21 AM

Open in Screener

CVM

Cel-Sci Corp

1.64

Aug 26 • 3:24 PM ET +0.16 (10.81%)

Healthcare Biotechnology USA Nano AMEX

Peers: BCDA BIVI CALC NEUP AIM APRE KAPA KPRX GOVX JAGX

| Held by: VTI VXF BUSM

Index	-
Market Cap	28.84M
Enterprise Value	30.21M
Income	-22.70M
Sales	0.00M
Book/sh	0.62
Cash/sh	0.37
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Dec 08, 1983

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	2.63
P/C	4.42
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.42
Current Ratio	1.48
Debt/Eq	0.72
LT Debt/Eq	0.47
Option/Short	No / Yes

EPS (ttm)	-2.58
EPS next Y	-3.07
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	25.29%
EPS past 3/5Y	37.90% 23.99%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.69%
Sales Y/Y TTM	-
EPS Q/Q	65.72%
Sales Q/Q	-
Earnings	Aug 17 BMO
EPS/Sales Surpr.	- -

Insider Own	6.38%
Insider Trans	80.37%
Inst Own	11.78%
Inst Trans	9.48%
ROA	-108.91%
ROE	-252.53%
ROIC	-140.57%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	11.11%
SMA50	27.61%
SMA200	-53.29%
Trades

Shs Outstand	17.59M
Shs Float	16.47M
Short Float	4.34%
Short Ratio	2.24
Short Interest	0.71M
52W High	13.48 -87.83%
52W Low	0.89 84.27%
Volatility	8.10% 8.78%
ATR (14)	0.13
RSI (14)	60.37
Beta	0.60
Rel Volume	0.83
Avg Volume	319.39K
Volume	242,924

Perf Week	0.00%
Perf Month	36.67%
Perf Quarter	16.31%
Perf Half Y	-62.64%
Perf YTD	-68.82%
Perf Year	-85.49%
Perf 3Y	-96.12%
Perf 5Y	-99.46%
Perf 10Y	-99.54%
Recom	1.00
Target Price	12.50
Prev Close	1.48
Price	1.64
Change %	10.81%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-20	Initiated	H.C. Wainwright	Buy	$18
Mar-02-15	Initiated	Dawson James	Buy	$3

Aug-17-26 08:30AM	CEL-SCI Reports Fiscal Third Quarter 2026 Results (Business Wire)
Aug-14-26 05:16PM	Cel-Sci: Fiscal Q3 Earnings Snapshot (Associated Press)
Aug-04-26 08:00AM	CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study (Business Wire) +8.80%
Jul-30-26 08:31AM	Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients (Business Wire) +7.02%
Jun-15-26 07:12AM	CVM Stock Sinks In Pre-Market Trading After Announcing Second Equity Raise For Its Cancer Drug In Just Over A Month (Stocktwits) -6.48%
05:32PM	Loading…
May-15-26 05:32PM	Cel-Sci: Fiscal Q2 Earnings Snapshot (Associated Press) +10.00% +20.28%
Feb-17-26 05:14PM	Cel-Sci: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +8.37%
Oct-20-25 09:00AM	CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 (TMX Newsfile)
Oct-10-25 08:00AM	CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference (TMX Newsfile)
Aug-14-25 10:45AM	CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results (Business Wire)
09:37AM	Cel-Sci: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
Aug-13-25 09:15AM	CEL-SCIs Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline (Business Wire) +9.44%
Jul-14-25 04:05PM	CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules (Business Wire)
Jul-11-25 12:16PM	CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules (Business Wire) -7.59%
09:15AM	CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer (Business Wire)
09:00AM	Loading…
Jun-18-25 09:00AM	FDAs Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCIs Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients (Business Wire)
May-23-25 04:05PM	CEL-SCI Announces Closing of Public Offering (Business Wire)
May-21-25 08:14PM	CEL-SCI Announces Pricing of Public Offering (Business Wire) -11.74% -45.45%
04:05PM	CEL-SCI Announces Proposed Public Offering (Business Wire)
08:00AM	CEL-SCIs Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia (Business Wire)
May-19-25 02:40PM	CEL-SCI Announces Combination of Common Stock (Business Wire) -8.61%
May-15-25 09:00AM	CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results (Business Wire)
May-14-25 07:30PM	Cel-Sci: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -6.84%
Apr-23-25 08:30AM	CEL-SCI to File for Regulatory Approval of Multikine in Saudi ArabiaPursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market (Business Wire) +5.20%
Apr-14-25 10:15AM	With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz (PR Newswire) -21.86%
Apr-08-25 09:51AM	New Study in the Scientific Journal "Cancer Cell" Supports CEL-SCIs Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses (Business Wire) -8.29%
Mar-24-25 09:00AM	CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients (Business Wire)
Mar-18-25 04:05PM	CEL-SCI Announces Closing of $2.5 Million Offering (Business Wire) +5.24%
Mar-17-25 03:24PM	CEL-SCI Announces Pricing of $2.5 Million Offering (Business Wire) -6.55%
08:00AM	CEL-SCIs Head and Neck Cancer Registration Study Protocol Clears FDA Reviewin Talks with Potential Partners Interested in Commercialization of Multikine (Business Wire)
08:30AM	Loading…
Mar-14-25 08:30AM	Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCIs Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression (Business Wire)
Feb-20-25 08:00AM	CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial (Business Wire) -17.50%
Feb-18-25 08:30AM	CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks (Business Wire) +6.91%
Feb-14-25 04:24PM	Cel-Sci: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
Jan-14-25 09:00AM	CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer (Business Wire)
Dec-31-24 04:05PM	CEL-SCI Announces Closing of $5 Million Offering (Business Wire)
Dec-29-24 08:41PM	CEL-SCI Announces Pricing of $5 Million Public Offering (Business Wire)
Dec-27-24 05:05PM	CEL-SCI Announces Proposed Public Offering of Common Stock (Business Wire) -14.87% -32.26%
Dec-12-24 09:15AM	CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study (Business Wire) +10.86%
Nov-07-24 08:15AM	U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025 (Business Wire) -7.92%
Oct-22-24 09:15AM	FDAs Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCIs Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer Patients (Business Wire)
Oct-01-24 06:00AM	CEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck Cancer (Business Wire)
Sep-16-24 07:30AM	CEL-SCIs Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and Radiation (Business Wire) -10.16%
Sep-10-24 09:32AM	CEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress (Business Wire)
Sep-04-24 09:00AM	The UKs Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine® One Step Closer to Future Marketing Clearance (Business Wire)
Aug-15-24 08:00AM	CEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial Results (Business Wire)
05:09AM	Cel-Sci: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
Jul-29-24 04:05PM	CEL-SCI Announces Closing of $10.8 Million Offering (Business Wire) -5.34%
Jul-26-24 11:52AM	CEL-SCI Announces Pricing of $10.8 Million Offering (Business Wire) +8.26%
08:23AM	CEL-SCIs Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical Results (Business Wire)
Jul-08-24 09:15AM	CEL-SCI Appoints Robert Watson as Chairperson of the Board (Business Wire)
Jun-18-24 08:00AM	CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population (Business Wire) -11.20%
Jun-06-24 07:00AM	Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor (Business Wire)
May-16-24 09:08AM	Cel-Sci: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
09:00AM	CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results (Business Wire)
May-08-24 04:02PM	Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine (MT Newswires) -16.77% +8.63%
09:00AM	CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer (Business Wire)
Apr-23-24 09:00AM	CEL-SCI Appoints Mario Gobbo to Its Board of Directors (Business Wire)
Mar-19-24 09:00AM	CEL-SCIs LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology (Business Wire)
Mar-06-24 08:45AM	CEL-SCI Corporation Issues Letter to Shareholders (Business Wire) +8.07%
Feb-15-24 08:00AM	CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results (Business Wire)
Feb-14-24 05:11PM	Cel-Sci: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
Feb-13-24 12:00PM	CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock (Business Wire)
Feb-09-24 08:30AM	CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock (Business Wire) -13.68%
Feb-06-24 09:00AM	CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug (Business Wire) +5.48%
Jan-31-24 09:00AM	European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine® (Business Wire)
Dec-22-23 08:00AM	CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments (Business Wire)
Dec-04-23 08:30AM	UKS National Institute for Health and Care Excellence (NICE) Selects CEL-SCIs Multikine as Potential New Standard of Care for Head & Neck Cancer (Business Wire) +35.27%
Nov-20-23 04:15PM	CEL-SCI Announces Closing of $5 Million Public Offering of Common Stock (Business Wire) +11.01%
Nov-16-23 08:30AM	CEL-SCI Announces Pricing of $5 Million Offering of Common Stock (Business Wire) -22.57%
Nov-09-23 08:52AM	12 Best Day Trading Stocks To Buy (Insider Monkey) -6.27%
Oct-30-23 09:20AM	CEL-SCI Issues Letter to Shareholders (Business Wire) +8.26%
Oct-24-23 08:00AM	CEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory Approvals (Business Wire)
Oct-23-23 09:15AM	5-Year Head & Neck Cancer Survival Increased From 45% to 73% in CEL-SCIs Target Population, Cutting Risk of Death in Half, as Presented at Leading Cancer Conference ESMO 2023 (Business Wire) +41.12%
Oct-19-23 08:00AM	CEL-SCI Readies Its Multikine Manufacturing Facility for Commercial Scale Production (Business Wire)
Oct-09-23 07:50AM	CVM: Regulatory Journey Accelerating (Zacks) -5.04%
Oct-05-23 08:45AM	CEL-SCI Files Request With the UKs MHRA Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancer (Business Wire) -6.03%
Sep-26-23 09:00AM	CEL-SCI Submits Scientific Advice Filing to European Medicines Agency (EMA) for Multikine in the Treatment of Head & Neck Cancer (Business Wire)
Aug-11-23 08:07AM	Cel-Sci: Fiscal Q3 Earnings Snapshot (Associated Press Finance) -12.68%
08:00AM	CEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Results (Business Wire)
Jul-31-23 05:49AM	CVM: Model Revisions (Zacks)
Jul-20-23 11:36AM	CEL-SCI Announces Closing of Public Offering (Business Wire) -8.80%
Jul-17-23 09:23PM	CEL-SCI Announces Pricing of Public Offering (Business Wire) +11.72% -23.43%
04:05PM	CEL-SCI Announces Proposed Public Offering of Common Stock (Business Wire)
Jul-14-23 09:15AM	CEL-SCI Concludes Positive Meeting With U.S. FDA Concerning Multikines Approval for Head & Neck Cancer (Business Wire) +9.40%
Jul-11-23 08:45AM	CEL-SCI Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikines Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer (Business Wire)
Jun-22-23 10:19AM	CEL-SCI to Present Novel Data at AHNS 11th International Conference on Head and Neck CancerNew Patent to Be Filed (Business Wire)
May-16-23 09:17AM	CVM: Health Canada Conditional Approval (Zacks Small Cap Research)
May-15-23 02:18PM	Why CEL-SCI Shares Are Shooting Higher Today (Benzinga) +8.33%
09:00AM	Histopathology and Tumor Biomarker Analysis Confirm CEL-SCIs Multikine Significantly Prolonged Overall Survival in Head & Neck CancerPhase 3 Data Presented at ESTRO 2023 (Business Wire)
May-12-23 04:35PM	Cel-Sci: Fiscal Q2 Earnings Snapshot (AP Finance) -11.44%
04:30PM	CEL-SCI Corporation Reports Second Quarter Fiscal 2023 Financial Results (Business Wire)
Apr-27-23 09:12PM	CEL-SCI Announces $1.35 Million Underwritten Confidentially Marketed Public Offering of Common Stock (Business Wire)
Apr-19-23 09:00AM	CEL-SCI to Pursue Canadas Conditional Approval Pathway for Multikine in the Treatment of Head & Neck Cancer (Business Wire) +15.04%
Mar-08-23 09:00AM	CEL-SCIs Multikine Phase 3 Cancer Study Shows 43% Survival Extension (Business Wire) -5.19%
Mar-03-23 09:00AM	CEL-SCI to Present New Phase 3 Data at European Congress on Head & Neck Oncology (Business Wire) +26.50%
Feb-27-23 05:26AM	CVM: BLA Filing Still on the Horizon (Zacks Small Cap Research)
Feb-15-23 09:00AM	CEL-SCI Corporation Reports First Quarter Fiscal 2023 Financial Results (Business Wire)
Jan-03-23 11:57AM	CVM: A New Year Ahead (Zacks Small Cap Research) +5.11%
Dec-28-22 09:00AM	CEL-SCI Reports Fiscal 2022 Financial Results and Clinical & Corporate Developments (Business Wire) +9.18%

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

CEOMr. Geert R. Kersten Esq.

Chief Financial & Operations OfficerMs. Patricia B. Prichep

Chief Scientific OfficerDr. Eyal Talor Ph.D.

Senior Vice President of Regulatory AffairsMr. John Cipriano

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KERSTEN GEERT R	Chief Executive Officer	Aug 25 '26	Buy	1.38	100,000	138,000	316,142	Aug 26 08:32 AM
KERSTEN GEERT R	Chief Executive Officer	May 14 '26	Buy	1.20	300,000	360,000	311,547	May 18 08:03 AM
KERSTEN GEERT R	Chief Executive Officer	May 13 '26	Buy	1.19	100,000	119,000	222,497	May 14 08:56 AM
KERSTEN GEERT R	Chief Executive Officer	Jan 22 '26	Buy	5.26	38,023	200,001	120,815	Jan 26 08:23 AM
KERSTEN GEERT R	Chief Executive Officer	Dec 04 '25	Buy	5.96	8,389	49,998	81,794	Dec 05 08:48 AM

Open in Screener

FTCI

FTC Solar Inc

2.17

Aug 26 • 3:23 PM ET +0.18 (9.05%)

Technology Solar USA Nano NASD

Peers: SPRU PN SPWR TYGO ENPH SEDG SHLS RUN ARRY CSIQ

| Held by: VTI VXF IWC

Index	-
Market Cap	35.85M
Enterprise Value	49.05M
Income	-52.20M
Sales	102.31M
Book/sh	-1.84
Cash/sh	0.67
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	232
IPO	Apr 28, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	0.35
P/B	-
P/C	3.24
P/FCF	-
EV/EBITDA	-
EV/Sales	0.48
Quick Ratio	0.71
Current Ratio	0.91
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-6.25
EPS next Y	-0.65
EPS next Q	-0.57
EPS this Y	85.45%
EPS next Y	18.63%
EPS next 5Y	67.60%
EPS past 3/5Y	16.69% -24.85%
Sales past 3/5Y	-6.78% -11.86%
EPS Y/Y TTM	5.67%
Sales Y/Y TTM	59.53%
EPS Q/Q	-43.47%
Sales Q/Q	30.83%
Earnings	Aug 05 BMO
EPS/Sales Surpr.	-279.78% 7.27%

Insider Own	29.82%
Insider Trans	1.32%
Inst Own	8.60%
Inst Trans	-3.50%
ROA	-57.67%
ROE	-863.70%
ROIC	-
Gross Margin	4.55%
Oper. Margin	-36.30%
Profit Margin	-51.02%
SMA20	-12.64%
SMA50	-40.71%
SMA200	-66.40%
Trades

Shs Outstand	16.46M
Shs Float	11.59M
Short Float	10.08%
Short Ratio	7.12
Short Interest	1.17M
52W High	12.75 -82.98%
52W Low	1.99 9.32%
Volatility	8.24% 11.16%
ATR (14)	0.28
RSI (14)	33.16
Beta	1.83
Rel Volume	3.97
Avg Volume	164.20K
Volume	594,771

Perf Week	-3.12%
Perf Month	-19.63%
Perf Quarter	-59.81%
Perf Half Y	-72.46%
Perf YTD	-80.11%
Perf Year	-68.91%
Perf 3Y	-88.40%
Perf 5Y	-97.95%
Perf 10Y	-
Recom	1.50
Target Price	8.88
Prev Close	1.99
Price	2.17
Change %	9.05%

Date	Action	Analyst	Rating Change	Price Target Change
May-06-26	Reiterated	TD Cowen	Buy	$8 → $5
Mar-06-26	Reiterated	TD Cowen	Buy	$12.50 → $8
Nov-17-25	Upgrade	Roth Capital	Neutral → Buy
Nov-13-25	Reiterated	TD Cowen	Buy	$8 → $12.50
Mar-14-24	Downgrade	ROTH MKM	Buy → Neutral
Nov-09-23	Downgrade	Northland Capital	Outperform → Market Perform	$0.65
Aug-15-23	Downgrade	UBS	Buy → Neutral	$4 → $2.50
Apr-13-23	Initiated	H.C. Wainwright	Buy	$5
Mar-15-23	Upgrade	BofA Securities	Underperform → Buy	$2 → $3.50
Jul-19-22	Upgrade	Piper Sandler	Underweight → Neutral	$2 → $3.50
Jun-06-22	Upgrade	ROTH Capital	Neutral → Buy
May-23-22	Initiated	Northland Capital	Outperform	$7
Apr-21-22	Downgrade	Piper Sandler	Neutral → Underweight	$4 → $3
Apr-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4
Jan-24-22	Downgrade	ROTH Capital	Buy → Neutral	$15 → $4
Jan-14-22	Downgrade	BofA Securities	Neutral → Underperform	$9 → $5
Dec-14-21	Initiated	Colliers Securities	Buy	$13
Oct-20-21	Upgrade	Barclays	Equal Weight → Overweight	$11 → $9
Jun-10-21	Initiated	Piper Sandler	Overweight	$15
Jun-09-21	Downgrade	BofA Securities	Buy → Neutral

Show Previous Ratings

Aug-06-26 08:30AM	FTC Solar, Inc. Q2 2026 Earnings Call Summary (Moby) -6.78%
Aug-05-26 06:44AM	FTC Solar: Q2 Earnings Snapshot (Associated Press)
06:30AM	FTC Solar Announces Second Quarter 2026 Financial Results (GlobeNewswire)
Jul-27-26 08:01AM	FTC Solar to Announce Second Quarter 2026 Financial Results Wednesday, August 5, 2026 (GlobeNewswire) +8.11%
Jul-08-26 08:00AM	FTC Solar Hosts Inaugural Robotics Day to Showcase the Future of Solar Construction (GlobeNewswire)
10:19AM	Loading…
May-05-26 10:19AM	FTC Solar (FTCI) Q1 Earnings Show Revenue Decline as CEO Transition Signals Strategic Reset (InvestorsHub) -33.20%
06:41AM	FTC Solar: Q1 Earnings Snapshot (Associated Press)
06:30AM	FTC Solar Announces First Quarter 2026 Financial Results and Leadership Transition (GlobeNewswire)
Apr-30-26 04:02PM	FTC Solar to Announce First Quarter 2026 Financial Results Tuesday, May 5, 2026 (GlobeNewswire) +7.33%
Mar-12-26 08:01AM	FTC Solar to Participate in Upcoming Investor Conferences (GlobeNewswire)
Mar-10-26 09:40AM	FTC Solar Lands 1-Gigawatt Deal Expansion With Strata Clean Energy (Benzinga) +8.87%
08:01AM	FTC Solar Announces 1,000MW Expansion to Tracker Supply Agreement with Strata Clean Energy (GlobeNewswire)
Mar-06-26 01:50AM	FTC Solar, Inc. (FTCI) Inks Multi-Year Solar Tracker Supply Agreement in South Africa (Insider Monkey) -23.03%
Mar-05-26 08:18PM	FTC Solar Q4 Earnings Call Highlights (MarketBeat) -27.11%
12:38PM	FTC Solar, Inc. Q4 2025 Earnings Call Summary (Moby)
09:05AM	Loading…
09:05AM	FTC Solar (FTCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
08:10AM	FTC Solar: Q4 Earnings Snapshot (Associated Press Finance)
07:45AM	FTC Solar Announces Fourth Quarter 2025 Financial Results (GlobeNewswire)
Mar-04-26 06:55PM	Vermilion Energy (VET) Q4 Earnings Beat Estimates (Zacks) +9.04%
Feb-26-26 07:30AM	Daqo New Energy (DQ) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Feb-24-26 10:45PM	Tigo Energy, Inc. (TYGO) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-23-26 08:01AM	FTC Solar Announces Supply Agreement with Lubanzi Inala (GlobeNewswire) -9.77%
Feb-20-26 08:01AM	FTC Solar to Announce Fourth Quarter and Full Year 2025 Financial Results Thursday, March 5, 2026 (GlobeNewswire)
Jan-14-26 09:40AM	Is Forum Energy Technologies (FET) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
Jan-13-26 08:02AM	FTC Solar Appoints Wes Fuller VP, North America Utility Sales (GlobeNewswire)
Jan-07-26 07:33AM	CSIQ Benefits From Strong Solar and Energy Storage Growth Momentum (Zacks)
Dec-29-25 08:48AM	First Solar's Expanding Footprint Positions It for Sustained Growth (Zacks)
Dec-17-25 07:56AM	SolarEdge Technologies to Benefit From Rising U.S. Solar Demand (Zacks) -5.85%
Dec-15-25 08:00AM	FTC Solar Appoints Anthony Carroll to Board of Directors (GlobeNewswire)
Dec-09-25 09:40AM	Is FTC Solar (FTCI) Stock Outpacing Its Oils-Energy Peers This Year? (Zacks)
08:19AM	Loading…
08:19AM	4 Solar Stocks to Watch With Robust Growth & Steady Long-Term Outlook (Zacks)
Nov-20-25 09:40AM	Are Oils-Energy Stocks Lagging DAQO New Energy (DQ) This Year? (Zacks) -6.33%
Nov-12-25 04:03PM	FTC Solar Inc (FTCI) Q3 2025 Earnings Call Highlights: Surpassing Revenue Expectations and ... (GuruFocus.com) +49.19%
07:45AM	FTC Solar (FTCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:41AM	FTC Solar: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-11-25 08:30AM	FTC Solar publishes white paper on Automation-Ready Construction with 1P Pioneer Tracker (GlobeNewswire)
Nov-10-25 05:55PM	Vaalco Energy (EGY) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -10.76%
Nov-06-25 06:05PM	Sunrun (RUN) Q3 Earnings and Revenues Top Estimates (Zacks) -5.15%
Nov-05-25 08:30AM	SolarEdge Technologies (SEDG) Reports Q3 Loss, Beats Revenue Estimates (Zacks) +7.83%
Oct-30-25 08:02AM	FTC Solar to Announce Third Quarter 2025 Financial Results Wednesday, November 12, 2025 (GlobeNewswire)
Oct-28-25 05:40PM	Tigo Energy, Inc. (TYGO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Sep-09-25 09:00AM	FTC Solar Launches Enhanced Pioneer+ Terrain Following Tracker at RE+ to Minimize Grading and Speed Installation (GlobeNewswire)
Sep-07-25 09:57AM	FTC Solar Secures a 1GW Solar Tracker, Software Agreement with Levona Renewables (Insider Monkey)
Sep-03-25 08:30AM	FTC Solar Launches Automated 80 High Angle Stow for 1P Pioneer Tracker to Maximize Hail Protection (GlobeNewswire)
Aug-26-25 08:04AM	FTC Solar Announces 1GW Tracker Agreement with Levona Renewables (GlobeNewswire) +5.76%
Aug-18-25 08:03AM	FTC Solar to Participate in Upcoming Investor Events (GlobeNewswire) +5.14%
Aug-14-25 07:00AM	FTC Solar Launches Pioneer+ High Wind Tracker to Expand Resilient Solar Deployment Options (GlobeNewswire)
Aug-05-25 07:45AM	FTC Solar (FTCI) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -18.46%
06:39AM	FTC Solar: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 10:11AM	FTC Solar Inc (FTCI) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +10.54%
Jul-31-25 08:30AM	FTC Solar Launches Safe Harbor Strategy Leveraging Module-Agnostic Universal Torque Tubes & Engineering Services Expertise to Enable Tax Credit Certainty (GlobeNewswire)
Jul-29-25 05:30PM	Tigo Energy, Inc. (TYGO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-23-25 08:00AM	FTC Solar to Announce Second Quarter 2025 Financial Results Tuesday, August 5, 2025 (GlobeNewswire) +10.02%
Jul-16-25 09:30AM	Solar Tracker Market Global Forecast and Company Analysis Report 2025-2029, with Profiles of Nextracker, Array Technologies, PVHardware, Soltec, Gamechange Solar, Arctech, FTC Solar, and More (GlobeNewswire)
Jul-08-25 08:25AM	FTC Solar enters $75M strategic financing facility (TipRanks)
Jul-07-25 08:02AM	FTC Solar Announces $75 Million Strategic Financing (GlobeNewswire)
May-21-25 11:15AM	ITC makes affirmative decision in Crystalline Silicon PV Cell investigations (TipRanks)
10:30AM	Trump Trade: Conservatives fight to end IRA tax credits sooner (TipRanks)
May-20-25 11:30AM	Solar stocks slip as conservatives fight to end IRA tax credits sooner (TipRanks) -5.17%
May-13-25 08:02AM	FTC Solar to Participate in Upcoming Investor Conferences (GlobeNewswire) +8.99%
May-02-25 03:07AM	FTC Solar Inc (FTCI) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... (GuruFocus.com) -5.72%
01:47AM	Q1 2025 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-25 04:10PM	FTC Solar, Inc. (FTCI) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:50AM	FTC Solar (FTCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:55AM	FTC Solar: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces First Quarter 2025 Financial Results (GlobeNewswire)
Apr-29-25 10:01AM	Array Technologies, Inc. (ARRY) Earnings Expected to Grow: Should You Buy? (Zacks)
Apr-24-25 08:01AM	FTC Solar to Announce First Quarter 2025 Financial Results Thursday, May 1, 2025 (GlobeNewswire) +10.99%
Apr-18-25 11:15AM	Exxon, Occidental projects at risk due to DOGE cuts, WSJ reports (TipRanks)
Apr-08-25 08:00AM	FTC Solar Introduces Revolutionary Dual-Row Configuration for 1P Pioneer Tracker : Industry's Highest East-West Slope Tolerance for a linked tracker (GlobeNewswire) -9.96%
Apr-02-25 08:36AM	FTC Solar price target lowered to $5 from $10 at TD Cowen (TipRanks) +7.27%
Apr-01-25 12:16PM	Rocket acquires Mr. Cooper, Musks xAI acquires X: Morning Buzz (TipRanks)
03:03AM	FTC Solar Inc (FTCI) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
12:41AM	Q4 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-31-25 02:18PM	FTC Solar, Inc. (FTCI) Q3 2024 Earnings Call Transcript (Seeking Alpha) +14.80%
07:40AM	FTC Solar (FTCI) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
06:48AM	FTC Solar: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Fourth Quarter 2024 Financial Results (GlobeNewswire)
Mar-24-25 08:01AM	FTC Solar to Announce Fourth Quarter and Full Year 2024 Financial Results Monday, March 31, 2025 (GlobeNewswire) +7.12%
Jan-14-25 08:00AM	FTC Solar Appoints Kent James Chief Commercial Officer (GlobeNewswire)
Dec-04-24 04:37PM	FTC Solar Announces Closing of Promissory Note Private Placement (GlobeNewswire) -6.48% -6.27%
Nov-28-24 08:11AM	FTC Solar announces 1-for-10 reverse stock split (TipRanks)
Nov-27-24 08:02AM	FTC Solar Announces Reverse Stock Split (GlobeNewswire) -9.08%
Nov-13-24 02:10AM	FTC Solar Inc (FTCI) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 11:34PM	Q3 2024 FTC Solar Inc Earnings Call (Thomson Reuters StreetEvents) -12.70%
07:45AM	FTC Solar (FTCI) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:42AM	FTC Solar: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	FTC Solar Announces Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 07:25AM	FTC Solar Inc (FTCI) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com) +7.00%
Nov-05-24 08:29AM	FTC Solar to supply trackers for 1GW Dunlieh Energy solar projects (Power Technology)
08:02AM	FTC Solar to Announce Third Quarter Financial Results Tuesday, November 12, 2024 (GlobeNewswire)
Nov-04-24 08:30AM	FTC Solar Announces 1GW Tracker Supply Agreement with Dunlieh Energy (GlobeNewswire)
Oct-24-24 08:25AM	FTC Solar to supply 1GW of projects for Sandhills Energy (TipRanks) +7.61%
Oct-23-24 08:02AM	FTC Solar to Supply Approximately 1GW of Projects for Sandhills Energy (GlobeNewswire)
Oct-09-24 05:37PM	FTC Solar Inc (FTCI) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)
Oct-08-24 08:50AM	Fast-paced Momentum Stock FTC Solar (FTCI) Is Still Trading at a Bargain (Zacks) -6.31%
Sep-20-24 10:23AM	FTC Solar, Inc. (FTCI): A Bull Case Theory (Insider Monkey) -6.85%
Sep-10-24 04:01PM	FTC Solar Announces Multi-Year Tracker Supply Agreement with Strata Clean Energy (GlobeNewswire) +5.68% +104.00%

FTC Solar, Inc. provides solar tracker systems, technology, software, and engineering services. Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation to the sun. The company was founded by David Springer and Ahmad R. Chatila in 2017 and is headquartered in Austin, TX.

PresidentMr. Anthony Carroll

Senior Vice President of Capital Markets & Business DevelopmentMr. Patrick M. Cook

Vice President of Investor Relations & Corporate CommunicationsMr. Bill Michalek

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carroll Anthony	Chief Executive Officer	Aug 25 '26	Buy	2.08	24,745	51,470	666,200	Aug 26 08:00 AM
YANN BRANDT	OFFICER	Jul 01 '26	Proposed Sale	5.00	370	1,850		Jul 01 12:18 PM
YANN BRANDT	OFFICER	Jun 24 '26	Proposed Sale	5.00	95,258	476,290		Jun 24 03:23 PM
ALVAREZ ANTONIO R	Director	May 07 '26	Buy	4.23	2,500	10,575	51,283	May 12 05:00 PM
ALVAREZ ANTONIO R	Director	May 06 '26	Buy	3.98	2,500	9,950	48,783	May 07 05:00 PM
Carroll Anthony	Chief Executive Officer	May 06 '26	Buy	3.43	7,250	24,868	641,455	May 07 09:13 AM
SADASIVAM SHAKER	Director	May 06 '26	Buy	3.70	27,025	99,992	81,508	May 07 09:10 AM
Behnen Cathy	CHIEF FINANCIAL OFFICER	Dec 30 '25	Sale	10.93	1,646	17,991	143,534	Dec 31 05:26 PM
Aminpour Sasan	Chief Operating Officer	Dec 30 '25	Sale	10.93	3,239	35,402	269,734	Dec 31 05:26 PM
Brandt Yann	Chief Executive Officer	Dec 30 '25	Sale	10.84	37,775	409,376	776,425	Dec 31 05:00 PM
YANN BRANDT	OFFICER	Dec 30 '25	Proposed Sale	10.79	37,775	407,499		Dec 30 05:44 PM
SASAN AMINPOUR	OFFICER	Dec 30 '25	Proposed Sale	10.88	3,239	35,229		Dec 30 05:42 PM
MARY CATHY BEHNEN	OFFICER	Dec 30 '25	Proposed Sale	10.93	1,646	17,987		Dec 30 05:39 PM
Carroll Anthony	Director	Dec 16 '25	Buy	9.53	10,638	101,380	24,205	Dec 18 08:00 AM
Springer David	Director	Nov 18 '25	Sale	8.98	100,000	898,000	689,222	Nov 20 06:00 PM
Springer David	Director	Nov 18 '25	Proposed Sale	9.60	100,000	960,000		Nov 18 05:00 PM

Peers: RMT CRF CLM CSQ ADX

Index	-
Market Cap	20.68M
Enterprise Value	-
Income	-
Sales	0.33M
Book/sh	2.83
Cash/sh	-
Dividend Est.	-
Dividend TTM	0.02 (0.71%)
Dividend Ex-Date	Dec 18, 2025
Dividend Gr. 3/5Y	73.80% -
Payout	18.96%
Employees	-
IPO	Apr 30, 1996

P/E	26.80
Forward P/E	-
PEG	-
P/S	63.15
P/B	1.04
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	0.11
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-79.40%
Sales Q/Q	-46.20%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	20.18%
Insider Trans	6.38%
Inst Own	19.06%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	1.37%
SMA50	1.02%
SMA200	4.52%
Trades

Shs Outstand	7.02M
Shs Float	5.60M
Short Float	0.11%
Short Ratio	1.05
Short Interest	0.01M
52W High	3.31 -10.94%
52W Low	2.40 22.82%
Volatility	1.93% 2.91%
ATR (14)	0.08
RSI (14)	53.82
Beta	0.15
Rel Volume	0.78
Avg Volume	5.71K
Volume	4,067

Perf Week	2.53%
Perf Month	0.26%
Perf Quarter	9.58%
Perf Half Y	2.71%
Perf YTD	14.70%
Perf Year	10.40%
Perf 3Y	58.89%
Perf 5Y	21.81%
Perf 10Y	130.29%
Recom	-
Target Price	-
Prev Close	2.93
Price	2.95
Change %	0.60%

Dec-04-25 02:52PM	RENN Fund, Inc. Announces Record Date For Year End Distribution 2025 (ACCESSWIRE)
Apr-02-25 04:25PM	RIV: Massive, Fully Covered Distribution At A Discount (Seeking Alpha)
Dec-16-24 05:40PM	RENN Fund, Inc. Announces Year End Distribution (ACCESSWIRE)
Nov-26-24 04:00PM	RENN Fund, Inc. Announces Record Date for Year End Distribution (ACCESSWIRE) -10.83%
Dec-14-23 02:05PM	RENN Fund, Inc. Announces Year End Distribution (ACCESSWIRE)
12:10PM	Loading…
Dec-04-23 12:10PM	Renn Fund, Inc. Announces Record Date for Year End Distribution (ACCESSWIRE)
May-05-23 08:42AM	Richardson Wealth Advisors Honoured on List of Canada's Top Women Advisors (PR Newswire)
Apr-03-23 10:33AM	RF CAPITAL REPORTS AUA OF $36 BILLION FOR MARCH 2023 AND ADDS THREE NEW ADVISORS (PR Newswire)
Dec-20-22 10:30AM	RENN Fund, Inc. Announces Year-End Distribution (ACCESSWIRE) +8.99%
Dec-09-22 10:35AM	Renn Fund, Inc. Announces Record Date for Year End Distribution (Business Wire)
Apr-05-22 08:00AM	MEDIA ADVISORY - RF CAPITAL TO ANNOUNCE Q1 2022 RESULTS AND HOST VIRTUAL AGM ON MAY 4, 2022 (PR Newswire)
Apr-01-22 03:23PM	RF CAPITAL REPORTS RECORD AUA OF $37.1 BILLION FOR MARCH 2022 (PR Newswire) +6.32%
Mar-30-22 07:30AM	RF Capital Completes Common Share Consolidation (PR Newswire)
Jan-27-22 03:17PM	CORRECTING and REPLACING RENN Fund, Inc. Announces Results of Rights Offering (Business Wire)
Dec-17-21 02:09PM	RENN Fund, Inc. Announces Year-End Distribution (Business Wire)
05:30PM	Loading…
Dec-09-21 05:30PM	RENN Fund, Inc. Announces Record Date for Year End Distribution (Business Wire) -6.02%
Dec-08-21 06:24PM	RENN Fund, Inc. Announces Rights Offering for Shares of Common Stock, Record Date and Summary of Terms (Business Wire)
Dec-03-21 09:52AM	RENN Fund, Inc. Announces Rights Offering for Shares of Common Stock, Record Date and Summary of Terms (Business Wire)
Apr-19-21 07:00AM	Dean Manjuris Joins Richardson Wealth as Vice-Chair to Support Ambitious Growth Agenda (PR Newswire)
Apr-15-21 10:33AM	MEDIA ADVISORY - RF Capital to Announce First Quarter 2021 Results May 10, 2021 (PR Newswire)
07:00AM	Richardson Wealth Named a Top 50 Best Workplace (PR Newswire)
Apr-09-21 09:45AM	RF Capital Board Once Again Determines That it Will Not Engage with Competitor's Unsolicited Proposal (PR Newswire)
Oct-20-20 07:58PM	RENN Fund, Inc. Announces Receipt of Proceeds from Petrohunter Energy Corporation (Business Wire)
Feb-11-19 03:35PM	RENN Fund, Inc. Announces Results of Rights Offering (Business Wire)
Dec-19-18 12:11PM	RENN Fund, Inc. Announces Rights Offering for Shares of Common Stock, Record Date and Summary of Terms (Business Wire)
Jun-30-17 01:03PM	RENN Fund, Inc. Shareholders Approve New Investment Advisor (Business Wire)
Jun-05-17 11:52AM	RENN Fund, Inc. Announces Adjournment of Special Meeting of Shareholders (Business Wire)
May-22-17 08:18AM	RENN Fund Board Recommends Shareholders Vote in Favor of All Proposals Contained in Definitive Proxy Dated April 28, 2017 (Business Wire)
Feb-09-17 04:01PM	MOVES-Barclays, Nasdaq, RenCap, AXA, BC Partners (Reuters)
Oct-19-16 09:00AM	RENN Fund Enters into Letter of Intent with Horizon Kinetics (Business Wire) +5.97%
03:14PM	Loading…
Aug-05-16 03:14PM	RENN Fund Announces Shareholder Approval of Plan of Liquidation and Dissolution (Business Wire)
Jul-25-16 03:08AM	RCG Corp. Ltd. :RCG-AU: Earnings Analysis: For the six months ended December 31, 2015 : July 25, 2016 (Capital Cube)
Jun-29-16 08:00AM	RENN Fund, Inc. Announces Postponement of its Annual Meeting (Business Wire)
Jun-28-16 01:51PM	RENN Fund, Inc. Acknowledges Receipt of Non-Binding Proposal from Etude Capital (Business Wire)
Jun-13-16 02:25PM	Etude Capital Delivers Letter to RENN Fund CEO, Board of Directors (PR Newswire)
May-31-16 10:02AM	[$$] High-security smartphone looks to dial up global elite (Financial Times)
Apr-29-16 01:50PM	Milford biotech slashes IPO size by 63% due to hepatitis B competition (bizjournals.com)
Apr-07-16 08:00AM	Etude Capital Comments on RENN Fund Liquidation (Business Wire)
Apr-05-16 08:00AM	RENN Fund, Inc. Board of Directors Approves Plan of Liquidation and Dissolution (Business Wire)
Jan-11-16 01:05PM	The Big 4 Theatre Stocks Underperformed In 2015...Will This Year Be Better? (Benzinga)
Dec-16-15 12:50PM	2015 IPOs a 'disappointment' by nearly every measure (bizjournals.com)
11:30AM	One Tampa Bay company stands out in a slow year for this benchmark (bizjournals.com)
Dec-08-15 01:13PM	RENN FUND, INC. Financials
Nov-19-15 03:29PM	How Square, Match Group IPOs affect Triangles tech entrepreneurs (bizjournals.com)
Jul-28-15 05:13PM	Move over Juno: This company just had the largest biotech IPO ever (bizjournals.com)
Apr-09-15 12:27PM	Carbylan Therapeutics raises $65M in IPO, stock rises on debut (bizjournals.com)
Apr-06-15 03:25PM	Carbylan Therapeutics revives IPO plans, chops target number (bizjournals.com)
03:00PM	Aduro Biotech hikes IPO target to $93 million (bizjournals.com)
Mar-31-15 07:48PM	GoDaddy tops targets with $440M IPO (bizjournals.com)
10:39AM	GoDaddy IPO this week comes at a slow time for tech offerings (bizjournals.com)
Mar-20-15 12:02AM	SteadyMed raises $40M in IPO that falls far short of expectations (bizjournals.com)
Mar-19-15 03:15PM	New study points to cracks in recent IPO boom (bizjournals.com)
Mar-17-15 03:15PM	SteadyMed hopes to break Bay Area IPO lull with $68.4M offering this week (bizjournals.com)
Mar-11-15 03:39PM	RENN FUND, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-09-15 01:40PM	Carbylan Therapeutics lines up $4M debt financing after putting off $93M IPO (bizjournals.com)
Feb-18-15 11:14AM	Carbylan Therapeutics postpones Wall Street debut amid slowing IPO market (bizjournals.com)
Feb-12-15 09:05AM	Genetic testing firm Invitae tops IPO targets, raises $102M (bizjournals.com)
Feb-09-15 10:55AM	Bay Area life science IPOs hope to get past last week's logjam (bizjournals.com)
Feb-02-15 12:19PM	2 more Bay Area life science IPOs coming this week, Invitae sets terms for next week (bizjournals.com)
Jan-26-15 11:35AM	After big Box debut, next 4 Bay Area IPOs are all in life sciences (bizjournals.com)
Dec-29-14 03:20PM	Year in Review: Houston sees fewer IPOs in 2014 (bizjournals.com)
Dec-26-14 02:47PM	Energy IPOs set a record in 2014 (bizjournals.com)
Dec-22-14 02:40PM	Pair of Columbus companies join in biggest year for IPOs since 2000 (bizjournals.com)
Sep-24-14 09:08PM	Interim for RCG Holdings Ltd. (Company Spotlight)
May-22-14 04:19AM	Weibo and Renren highlight troubles facing Chinese web groups (Financial Times)
Mar-15-13 08:22AM	RENN Global: A Cheap, Interesting And Speculative CEF (Seeking Alpha)
Dec-14-12 05:00PM	RENN Global Entrepreneurs Fund, Inc. Announces Resignation of Chief Financial Officer and Appointment of Acting Chief Financial Officer (Business Wire)
May-04-12 06:46AM	Facebook narrows in on IPO price (bizjournals.com)
Mar-05-12 10:14AM	13 Great Senior Discounts (TheStreet)
Feb-14-12 06:47AM	Investing In Emerging Technologies (Seeking Alpha)
Feb-10-12 11:46AM	Shut up and buy the tech bubble? Heck yeah. (MarketWatch)
Jan-11-12 05:20PM	Two trades for this market (MarketWatch)
Jan-04-12 03:29PM	Cody Willard: One of the ten must-own tech stocks for 2012 (MarketWatch)
10:05AM	Amazon is very oversold and other must-reads (MarketWatch)
Dec-09-11 10:03PM	Chicago broker shows 'em the money post MF Global (Reuters)
Dec-04-11 12:12PM	CEF Weekly Review: World Equity Funds Surge (Seeking Alpha)
Oct-27-11 04:26PM	Stock picks for tech traders and other must-reads (MarketWatch)
Sep-27-11 04:24PM	Investment Industry Regulatory Organization of Canada - Trade Resumption - Almonty Industries Inc. (formerly RCG Capital Inc.) - AII (formerly RCG.P) (PR Newswire)
Sep-06-11 08:39AM	RENN Global Entrepreneurs Fund: Much Risk And Much Appeal (Seeking Alpha)
Aug-03-11 08:30AM	Wall Street 1-2-1 Unveils Confirmed Schedule and Prestigious Speaker Line-Up for Upcoming Event at Ritz-Carlton Hotel Grande Lakes on September 13-16, 2011 (Marketwire)
Jun-29-11 04:41PM	Youku.com shares on a rollercoaster, but that's no surprise (MarketWatch)
Apr-17-11 08:55AM	China's Leading Social Networking Site Files for $531M IPO (Seeking Alpha)
Apr-09-11 08:38PM	[video] Kevin Harrington: Forget Banks, Come to ABC's 'Shark Tank' (TheStreet.com)
Apr-08-11 07:30AM	[video] Kevin Harrington: Forget Banks Come to ABC's Shark Tank (TheStreet.com)
Oct-04-10 01:45PM	[$$] A Look at More Media Stock Picks (TheStreet.com)
Sep-12-10 06:10AM	CEF Weekly Review: Service Economy Slowly Advances (Seeking Alpha)
Sep-09-10 02:21AM	Peter Brimelow: Fund service grinds out gains (MarketWatch)
Apr-19-10 09:00AM	RENN Global Entrepreneurs Fund, Inc. Announces the Annual Meeting and RENN Investor Conference (Business Wire)
Dec-31-09 08:41AM	[$$] 3D Could Make Movie Theater Stocks Pop (Barrons.com)
Jun-16-09 12:39AM	[$$] Is Big Runup That Big a Deal? (Barron's Online)
May-20-09 08:54AM	Shareholders Approve Change to a Registered Non-Diversified Closed-End Fund and Changed the Name to RENN Global Entrepreneurs Fund, Inc. (Business Wire)
May-12-09 12:20PM	RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Apr-22-09 08:53AM	Renaissance Capital Growth & Income Fund III, Inc. Announces its Annual Meeting and RENN Investor Conference (Business Wire)
Apr-02-09 12:06PM	RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC Files SEC form 10-K/A, Annual Report (EDGAR Online)
Mar-30-09 04:27PM	RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC Files SEC form 10-K, Annual Report (EDGAR Online)
Feb-20-09 01:50PM	Renaissance Capital Changes Special Shareholders Meeting Date (Business Wire)
Jan-09-09 08:15AM	RCG Board of Directors Recommends Important Structure Change for The Fund (Business Wire)
Nov-12-08 12:22PM	RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Sep-26-08 08:15AM	Renaissance Capital Announces Third Quarter Distribution of $0.10 Per Share (Business Wire)
Aug-29-08 04:30PM	RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC Files SEC form 8-K, Other Events (EDGAR Online)

RENN Fund, Inc. is a closed ended equity mutual fund launched by RENN Capital Group, Inc. The fund is co-managed by Horizon Kinetics Asset Management LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It seeks to invest in stocks of small-cap and mid-cap companies. The fund employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio. It was formerly known as RENN Global Entrepreneurs Fund, Inc. RENN Fund, Inc. was formed on January 20, 1994 and is domiciled in the United States.

Vice PresidentMr. Z. Eric Stephens CFA

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kesslen Jay H	Vice-President	Aug 25 '26	Buy	2.93	1,000	2,930	45,880	Aug 26 12:22 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 25 '26	Buy	2.95	756	2,230	957,612	Aug 26 09:56 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 24 '26	Buy	2.95	756	2,230	956,856	Aug 25 01:31 PM
Kesslen Jay H	Vice-President	Aug 24 '26	Buy	2.95	1,000	2,950	44,880	Aug 24 04:16 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 21 '26	Buy	2.87	756	2,170	956,100	Aug 24 01:24 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 20 '26	Buy	2.95	756	2,230	955,344	Aug 21 03:58 PM
Kesslen Jay H	Vice-President	Aug 21 '26	Buy	2.87	1,000	2,870	43,880	Aug 21 10:54 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 19 '26	Buy	2.88	756	2,177	954,588	Aug 20 02:05 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 18 '26	Buy	2.80	756	2,117	953,832	Aug 19 11:14 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 17 '26	Buy	2.82	756	2,132	953,076	Aug 18 11:05 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 14 '26	Buy	2.80	756	2,117	952,320	Aug 17 10:22 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 13 '26	Buy	2.90	756	2,192	951,564	Aug 14 11:10 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 12 '26	Buy	2.90	756	2,192	950,808	Aug 13 11:56 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 11 '26	Buy	2.99	756	2,260	950,052	Aug 12 02:37 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 10 '26	Buy	2.96	756	2,238	949,296	Aug 11 11:21 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 07 '26	Buy	3.00	756	2,268	948,540	Aug 10 01:16 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 06 '26	Buy	2.97	756	2,245	947,784	Aug 07 12:04 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 05 '26	Buy	2.97	756	2,245	947,028	Aug 06 10:04 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 04 '26	Buy	3.06	756	2,313	946,272	Aug 05 01:57 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Aug 03 '26	Buy	3.02	756	2,283	945,516	Aug 04 11:41 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 31 '26	Buy	3.03	756	2,291	944,760	Aug 03 10:56 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 30 '26	Buy	3.06	756	2,313	944,004	Jul 31 11:06 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 29 '26	Buy	3.04	756	2,298	943,248	Jul 30 03:08 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 28 '26	Buy	3.05	756	2,306	942,492	Jul 29 12:59 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 27 '26	Buy	3.03	756	2,291	941,736	Jul 28 10:01 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 24 '26	Buy	3.02	756	2,283	940,980	Jul 27 11:58 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 23 '26	Buy	3.06	756	2,313	940,224	Jul 24 01:09 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 22 '26	Buy	3.06	756	2,313	939,468	Jul 23 12:40 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 21 '26	Buy	3.07	756	2,321	938,712	Jul 22 10:22 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 20 '26	Buy	3.03	756	2,291	937,956	Jul 21 11:42 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 17 '26	Buy	3.02	756	2,283	937,200	Jul 20 11:58 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 16 '26	Buy	3.02	756	2,283	936,444	Jul 17 12:00 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 15 '26	Buy	3.00	756	2,268	935,688	Jul 16 12:57 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 14 '26	Buy	3.02	756	2,283	934,932	Jul 15 12:08 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 13 '26	Buy	3.00	756	2,268	934,176	Jul 14 11:59 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 10 '26	Buy	3.02	756	2,283	933,420	Jul 13 11:50 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 09 '26	Buy	3.02	756	2,283	932,664	Jul 10 11:12 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 08 '26	Buy	3.02	756	2,283	931,908	Jul 09 11:33 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 07 '26	Buy	3.04	756	2,298	931,152	Jul 08 03:58 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 06 '26	Buy	3.01	756	2,276	930,396	Jul 07 12:52 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 02 '26	Buy	3.11	756	2,351	929,640	Jul 06 11:39 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jul 01 '26	Buy	3.09	756	2,336	928,884	Jul 02 12:35 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 30 '26	Buy	2.93	756	2,215	928,128	Jul 01 11:44 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 29 '26	Buy	2.85	756	2,155	927,372	Jun 30 09:45 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 26 '26	Buy	2.79	756	2,109	926,616	Jun 29 12:33 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 25 '26	Buy	2.73	756	2,064	925,860	Jun 26 11:27 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 24 '26	Buy	2.76	756	2,087	925,104	Jun 25 11:42 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 23 '26	Buy	2.75	756	2,079	924,348	Jun 24 10:33 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 22 '26	Buy	2.78	756	2,102	923,592	Jun 23 12:56 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 18 '26	Buy	2.83	756	2,139	922,836	Jun 22 02:13 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 17 '26	Buy	2.85	756	2,155	922,080	Jun 18 11:02 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 16 '26	Buy	2.74	756	2,071	921,324	Jun 17 04:02 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 15 '26	Buy	2.85	756	2,155	920,568	Jun 16 02:33 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 12 '26	Buy	2.75	756	2,079	919,812	Jun 15 10:42 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 11 '26	Buy	2.75	756	2,079	919,056	Jun 12 12:22 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 10 '26	Buy	2.75	756	2,079	918,300	Jun 11 10:46 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 09 '26	Buy	2.75	756	2,079	917,544	Jun 10 11:54 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 08 '26	Buy	2.76	756	2,087	916,788	Jun 09 10:49 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 05 '26	Buy	2.82	756	2,132	916,032	Jun 08 12:02 PM
DOYLE PETER	Co-Portfolio Manager	Jun 04 '26	Buy	2.72	300	816	1,800	Jun 05 01:53 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 04 '26	Buy	2.75	756	2,079	915,276	Jun 05 01:40 PM
DOYLE PETER	Co-Portfolio Manager	Jun 03 '26	Buy	2.75	400	1,100	1,500	Jun 04 03:52 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 03 '26	Buy	2.75	756	2,079	914,520	Jun 04 11:17 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 02 '26	Buy	2.71	756	2,049	913,764	Jun 03 11:13 AM
HORIZON KINETICS ASSET MANAGEM	10% Owner	Jun 01 '26	Buy	2.75	756	2,079	913,008	Jun 02 12:36 PM
DOYLE PETER	Co-Portfolio Manager	Jun 01 '26	Buy	2.71	500	1,355	1,100	Jun 02 12:35 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	May 29 '26	Buy	2.89	756	2,185	912,252	Jun 01 12:25 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	May 28 '26	Buy	2.73	756	2,064	911,496	May 29 01:36 PM
HORIZON KINETICS ASSET MANAGEM	10% Owner	May 27 '26	Buy	2.70	756	2,041	910,740	May 29 01:36 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 07 '26	Buy	3.24	774	2,508	367,858	Apr 09 05:19 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 07 '26	Buy	3.24	360	1,166	160,688	Apr 09 05:19 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 06 '26	Buy	3.05	774	2,361	367,562	Apr 07 11:50 AM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 06 '26	Buy	3.05	360	1,098	160,328	Apr 07 11:50 AM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 02 '26	Buy	3.27	774	2,531	367,266	Apr 06 02:39 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 02 '26	Buy	3.27	360	1,177	159,968	Apr 06 02:39 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 01 '26	Buy	3.25	774	2,516	366,970	Apr 02 01:04 PM
STAHL MURRAY	President/Co-Portfolio Manager	Apr 01 '26	Buy	3.25	360	1,170	159,608	Apr 02 01:04 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 31 '26	Buy	3.24	774	2,508	366,674	Apr 01 12:02 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 31 '26	Buy	3.24	360	1,166	159,248	Apr 01 12:02 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 30 '26	Buy	3.25	774	2,516	366,378	Mar 31 02:19 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 30 '26	Buy	3.25	354	1,150	158,888	Mar 31 02:19 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 27 '26	Buy	3.25	774	2,516	366,082	Mar 30 12:58 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 27 '26	Buy	3.25	360	1,170	158,534	Mar 30 12:58 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 26 '26	Buy	3.29	774	2,546	365,786	Mar 27 12:16 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 26 '26	Buy	3.29	360	1,184	158,174	Mar 27 12:16 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 25 '26	Buy	3.28	774	2,539	365,490	Mar 26 12:23 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 25 '26	Buy	3.28	360	1,181	157,814	Mar 26 12:23 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 24 '26	Buy	2.97	774	2,297	365,194	Mar 25 12:12 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 24 '26	Buy	3.20	360	1,152	157,454	Mar 25 12:12 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 23 '26	Buy	3.28	774	2,539	364,898	Mar 24 02:45 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 23 '26	Buy	3.28	360	1,181	157,094	Mar 24 02:45 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 20 '26	Buy	3.26	774	2,523	364,602	Mar 23 11:08 AM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 20 '26	Buy	3.26	360	1,174	156,734	Mar 23 11:08 AM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 19 '26	Buy	3.18	774	2,461	364,306	Mar 20 01:38 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 19 '26	Buy	3.18	360	1,145	156,374	Mar 20 01:38 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 18 '26	Buy	3.18	774	2,461	364,010	Mar 19 02:06 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 18 '26	Buy	3.18	360	1,145	156,014	Mar 19 02:06 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 18 '26	Buy	3.18	774	2,461	364,010	Mar 19 01:35 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 18 '26	Buy	3.18	360	1,145	156,014	Mar 19 01:35 PM
STAHL MURRAY	President/Co-Portfolio Manager	Mar 17 '26	Buy	3.27	774	2,531	363,714	Mar 18 03:53 PM

PRE

Prenetics Global Limited

AMRZ

Amrize Ltd

CVM

Cel-Sci Corp

FTCI

FTC Solar Inc

RCG

RENN Fund Inc

Upgrade your Finviz experience